GAM
WST icon

Groupama Asset Management’s West Pharmaceutical WST Stock Holding History

Groupama Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$374K Buy
1,054
+7
+0.7% +$2.14K ﹤0.01% 350
2026
Q1 		$262K Sell
1,047
-483
-32% -$120K ﹤0.01% 365
2025
Q4 		$421K Sell
1,530
-97
-6% -$26.5K 0.01% 360
2025
Q3 		$427K Buy
+1,627
New +$395K 0.01% 374
2024
Q4 		– Sell
-2,308
Closed -$556K – 509
2024
Q3 		$556K Buy
2,308
+1,786
+342% +$547K 0.01% 339
2024
Q2 		$172K Hold
522
– – ﹤0.01% 417
2024
Q1 		$207K Hold
522
– – ﹤0.01% 433
2023
Q4 		$184K Buy
+522
New +$185K ﹤0.01% 381

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Groupama Asset Management's WST Position: Q2 2026 in Review

Groupama Asset Management increased its West Pharmaceutical (WST) stake by 0.67% in Q2 2026, buying an estimated $2.14K and bringing the position to 1,054 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #350.

Groupama Asset Management first reported a position in WST in Q4 2023 and has held it in 8 quarters since. The position peaked at $556K in Q3 2024. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Groupama Asset Management held 1,054 shares of West Pharmaceutical worth $374K as of Q2 2026.
  • Groupama Asset Management bought 7 West Pharmaceutical shares in Q2 2026, an estimated $2.14K.
  • West Pharmaceutical made up ﹤0.01% of Groupama Asset Management's portfolio in Q2 2026, its #350 holding.
  • Groupama Asset Management first reported a position in West Pharmaceutical in Q4 2023 and has held it in 8 quarters since.
  • Groupama Asset Management's West Pharmaceutical position peaked at $556K in Q3 2024.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.